Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, and Interbody products.
Company Information
About this company
Key people
Sean E. Browne
President, Chief Executive Officer, Director
Scott C. Neils
Chief Financial Officer
Mark A. Schallenberger
Chief Operating Officer
Stavros G. Vizirgianakis
Independent Chairman of the Board
Abhinav Jain
Director
Tyler P. Lipschultz
Director
John K. Bakewell
Independent Director
Jonn R. Beeson
Independent Director
Click to see more
Key facts
- Shares in issue140.00m
- EPICXTNT
- ISINUS98420P3082
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$81.48m
- Employees217
- ExchangeNyse American LLC
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.